CureVac: Vaccine data are ”sobering” full results in weeks


PTI, Jun 17, 2021, 7:04 PM IST

Berlin: The chief executive of CureVac said Thursday that interim results from late-stage testing of its coronavirus shot are “sobering,” but the German company aims to finish a final analysis within weeks that will determine whether it will still seek regulatory approval.

CureVac announced late Wednesday that the vaccine had shown an efficacy of 47% against COVID-19 of any severity, according to a partial review of data from its trial involving 40,000 participants in Latin America and Europe. This is below the World Health Organization threshold of 50 per cent.

The biotechnology company said more than two dozen variants of the coronavirus were found in its trial across 10 countries, a fact that may have affected the outcome.

“The results are sobering,” said chief executive Franz-Werner Haas. “We recognize that demonstrating high efficacy in this unprecedented broad diversity of variance is quite challenging.”

Still, CureVac said it will continue to analyze data from the trial and this may affect the final outcome.

“We are going full-speed for final readout,” said Haas, adding that the company expects to reach that point in 2-3 weeks.

Meanwhile, CureVac is also working on a second-generation vaccine, aiming to start trials this fall.

The German government, which invested 300 million euros ($358 million) in CureVac last year, said the disappointing results won”t affect its initial vaccine campaign.

Chancellor Angela Merkel”s chief of staff, Helge Braun, told media group RND that the government remains committed to offering every citizen a vaccine by the end of September.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

10 month baby gets new heart, new life

Actress Kasthuri released from jail, says ‘I thank those who made me raging storm’

Kidnapped for ransom in 1998, 26/11 survivor Gautam Adani faces biggest trial

100 engineering colleges in Karnataka to be ‘adopted’ by corporates by next year: IT Minister Kharge

Siddaramaiah defends BPL ration card cancellation, says only ineligible beneficiaries affected

China announces new policy measures to protect its exports from Trump’s new tariff threat

Renovated Medical Oncology OPD and Chemotherapy Day Care Centre inaugurated at Kasturba Hospital, Manipal

Related Articles More

India-US ties have strong foundation: White House confident in navigating crisis over Adani bribery charges

PM Modi leaves for home after concluding three-nation visit

China announces new policy measures to protect its exports from Trump’s new tariff threat

Pak government prepares for proposed protest by former PM Imran Khan’s party on Nov 24

Gangster Lawrence Bishnoi’s brother Anmol arrested in US, lodged in Iowa jail

MUST WATCH

Christmas Cake Fruit Mixing

DK Shivakumar

Rose Cultivation

Geethotsava

Naxal Operation


Latest Additions

‘Bengaluru Chalo’ protest demand rejection of Kasturirangan Report

Mangaluru: Cyber frauds posing as TRAI representatives fleece Rs 1.71 crore

10 month baby gets new heart, new life

Saura Swasthya launched: Karnataka to power 5,000 health facilities with solar energy

India-US ties have strong foundation: White House confident in navigating crisis over Adani bribery charges

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.